Orbimed Capital LLC, 10% Owner at Arcutis Biotherapeutics, Inc. (ARQT), sold 1,226,600 shares at $20.66 ($25.4M) on 2022-04-07, disclosed to the SEC on 2022-04-08.
Open-market sale of $25.4M ARQT by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.69 | 162,000 | $3.4M | 13.2% |
| 2 | $20.69 | 171,204 | $3.5M | 14.0% |
| 3 | $20.69 | 171,204 | $3.5M | 14.0% |
| 4 | $20.66 | 167,800 | $3.5M | 13.7% |
| 5 | $20.66 | 177,196 | $3.7M | 14.4% |
| 6 | $20.66 | 177,196 |
| $3.7M |
| 14.4% |
| 7 | $20.71 | 97,200 | $2.0M | 7.9% |
| 8 | $20.71 | 102,800 | $2.1M | 8.4% |
| Total | $20.68 avg | 1,226,600 | $25.4M | 100% |
| Filing → |
| PRLD | BUY | 2023-05-24 | $10.0M | — | Filing → |
| RPTX | SELL | 2021-08-30 | $993K | — | Filing → |
| RPTX | SELL | 2021-08-25 | $1.2M | — | Filing → |